🇺🇸 Glucagon Nasal Powder in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 1
Most-reported reactions
- Renal Failure — 1 report (100%)
Other Endocrinology approved in United States
Frequently asked questions
Is Glucagon Nasal Powder approved in United States?
Glucagon Nasal Powder does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Glucagon Nasal Powder in United States?
Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.